Skip to Main Content

Author Details

Daniel J Coleman
Knight Cancer Institute, Oregon Health & Science University
2007
24
12
PMIDPaper TitleJournal TitlePublished Year
36526735Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors.Leukemia2023
36976323Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia.Mol Cancer Res2023
36998071CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma.Mol Cancer2023
36894620RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.Leukemia2023
35590033PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia.Leukemia2022
35788238GoPeaks: histone modification peak calling for CUT&Tag.Genome Biol2022
34145028BET Bromodomain Inhibition Blocks an AR-Repressed, E2F1-Activated Treatment-Emergent Neuroendocrine Prostate Cancer Lineage Plasticity Program.Clin Cancer Res2021
32403054Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.Neoplasia2020
32471953Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.Proc Natl Acad Sci U S A2020
30846826Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.Sci Rep2019
31565603Molecular Testing Identifies Determinants of Exceptional Response and Guides Precision Therapy in a Patient with Lethal, Treatment-emergent Neuroendocrine Prostate Cancer.Cureus2019
30996246BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.Oncogene2019
29581250LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.Proc Natl Acad Sci U S A2018
28754339IL-1 Receptor-Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation.J Invest Dermatol2017
29340039Integrative molecular network analysis identifies emergent enzalutamide resistance mechanisms in prostate cancer.Oncotarget2017
27276681Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.Oncotarget2016
26563191Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts.Invest New Drugs2016
25189354Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment.Mol Cancer Res2015
24407555Grp1-associated scaffold protein regulates skin homeostasis after ultraviolet irradiation.Photochem Photobiol Sci2014
24810760Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation.PLoS Genet2014
23279852Endothelin-1 is a transcriptional target of p53 in epidermal keratinocytes and regulates ultraviolet-induced melanocyte homeostasis.Pigment Cell Melanoma Res2013
20944655RXRα ablation in epidermal keratinocytes enhances UVR-induced DNA damage, apoptosis, and proliferation of keratinocytes and melanocytes.J Invest Dermatol2011
20026005A long-wavelength fluorescent substrate for continuous fluorometric determination of alpha-mannosidase activity: resorufin alpha-D-mannopyranoside.Anal Biochem2010
17927946A long-wavelength fluorescent substrate for continuous fluorometric determination of cellulase activity: resorufin-beta-D-cellobioside.Anal Biochem2007
  • 1 - 24 of 24

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 6
Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 3
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 1
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Rahul K Kollipara
McDermott Center for Human Growth and Development.
Career Start Year 2010
Number of shared co-authors 5
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 0
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 16
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 8
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 6
Leigh Ellis
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 2007
Number of shared co-authors 10
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 6
Daniel Schramek
University of Toronto
Career Start Year 2005
Number of shared co-authors 1
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 10
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 5
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 7
Kristiina Iljin
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 16
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 5
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 6
Eldad Zacksenhaus
University of Toronto
Career Start Year 1988
Number of shared co-authors 1
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 1
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 14
Ralf Kittler
McDermott Center for Human Growth and Development.
Career Start Year 1984
Number of shared co-authors 5
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 1
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Joshi J Alumkal
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 8
Jacob Schwartzman
12286Rutgers - New Jersey Medical School
Co-authored papers 7
Joshua Urrutia
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Co-authored papers 7
Julia E Maxson
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Theodore P Braun
Oregon Health & Science University
Co-authored papers 6
Carly J King
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
Lina Gao
Oregon National Primate Research Center
Co-authored papers 5
Laura M Heiser
Oregon Health Sciences University
Co-authored papers 5
Brian J Druker
Oregon Health & Science University
Co-authored papers 4
David Sampson
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Co-authored papers 4
Archana Sehrawat
Knight Cancer Institute and.
Co-authored papers 4
Cody Coblentz
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Zachary Schonrock
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Joseph Estabrook
Cancer Early Detection Advanced Research Center, Oregon Health & Science University
Co-authored papers 3
Thomas J George
UF Health Cancer Center
Co-authored papers 2
Colm Morrissey
Co-authored papers 2
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 2
Sarah A Carratt
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Ilsa Coleman
Fred Hutchinson Cancer Center
Co-authored papers 2
Eva Corey
University of Washington School of Medicine
Co-authored papers 2
Emek Demir
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Dae Hwan Kim
Nanoori Gangnam Hospital
Co-authored papers 2
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 2
James E Korkola
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Kami E Chiotti
Oregon Health & Science University
Co-authored papers 2
Robert Lisac
University of Florida College of Medicine - Jacksonville
Co-authored papers 2
Tomasz M Beer
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Nicola Long
Oregon Health and Science University
Co-authored papers 1
Jared Bearss
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Release 1.2